The study of monoclonal antibodies (MAbs) is a field of great interest to science medicine, for example, anti-TNF agents (infliximab and adalimumab) represent an important tool for the management of autoimmune and inflammatory disorders. To characterize the physical parameters that could be involved in the kinetic behaviour of MAbs and study the interaction with their antigens, could be helpful to increase the MAbs kinetics and improve their efficiency. The authors of this paper consider that the total kinetic MAbs has two principal components: transport kinetics and chemical kinetics. In this work we focus on the physical description of the transport kinetics of MAbs in a fluid with laminar flow and parabolic profile and, we present some physical considerations necessary to take into account in the study of antigen-MAbs interactions with intention to integrate the information of chemical kinetics with our model of the transport kinetics. To simulate the kinetics of the MAbs, standard equations were solved numerically (using The Verlet algorithm) to calculate the motion of a particle with a spherically symmetric inside of parabolic laminar flow, in order to find the time evolution of the antibody velocity in blood plasma in function of the increase of the radius, mass and density of the MAbs, and the fluid pressure in blood vessels. In this work we used the physical parameters that characterize the monoclonal antibody "infliximab", which is administered by intravenous infusion and is distributed predominantly in the vascular field. We take the mesenteric blood flow as a laminar flow. In the case of we fixed the value of the antibody density, their kinetics increased when the pressure in the vessels increased. When we fixed the pressure in the vessels we found: if we reduce the antibody radius their kinetics increased, and when we increase antibody density we found that their kinetics also increased. From these results we predict that MAb transport kinetics increases with decreasing of their volume. This result could improve the therapy effectiveness using MAbs. [ABSTRACT FROM AUTHOR]